USD10
GNLX Shares
About GeneluxGenelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
USD10
GNLX Shares
About GeneluxGenelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$109.49M
OPEN PRICE
$2.48
LOW (1Y)
$2.29
HIGH (1Y)
$8.54
LOW (24H)
$2.36
HIGH (24H)
$2.52
VOLUME (24H)
$277.87K
65.11%
Price history
Time | Price | Change |
|---|---|---|
Today | $2.48 | |
1 Day | $2.49 | |
1 Week | $2.58 | |
1 Month | $2.46 | |
1 Year | $6.51 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Popular prediction markets
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.